一名复发性外阴癌患者对厄洛替尼的长期反应：病例报告及文献综述
Long term response to erlotinib in a patient with recurrent vulvar carcinoma: Case report and review of literature.
作者信息
Inrhaoun Hanane, Elghissassi Ibrahim, Gutierrez Maya, Brain Etienne, Errihani Hassan
机构信息
Department of Medical Oncology, Hôpital René Huguenin (Institut Curie), 35 rue Dailly 92210 Saint-Cloud, France.
Department of Medical Oncology, National Institute of Oncology, Allal Elfassi Street, Rabat, Morocco.
出版信息
Gynecol Oncol Case Rep. 2012 Jul 27;2(4):119-20. doi: 10.1016/j.gynor.2012.07.002. eCollection 2012.
Abstract
► We report a case of recurrent vulvar carcinoma with a good response to erlotinib. ► Treatment was well tolerated with no serious side effects. ► Further evaluation of this new therapeutic approach may be warranted.
摘要
► 我们报告了一例对厄洛替尼反应良好的复发性外阴癌病例。
► 治疗耐受性良好，无严重副作用。
► 可能有必要对这种新的治疗方法进行进一步评估。
相似文献
1
Long term response to erlotinib in a patient with recurrent vulvar carcinoma: Case report and review of literature.一名复发性外阴癌患者对厄洛替尼的长期反应：病例报告及文献综述
Gynecol Oncol Case Rep. 2012 Jul 27;2(4):119-20. doi: 10.1016/j.gynor.2012.07.002. eCollection 2012.
2
A case of recurrent vulvar carcinoma treated with erlotinib, an EGFR inhibitor.
Eur J Gynaecol Oncol. 2011;32(4):423-4.
3
Treatment of squamous cell vulvar cancer with the anti-EGFR tyrosine kinase inhibitor Tarceva.使用抗表皮生长因子受体（EGFR）酪氨酸激酶抑制剂特罗凯治疗外阴鳞状细胞癌。
Gynecol Oncol. 2007 Sep;106(3):628-30. doi: 10.1016/j.ygyno.2007.05.006. Epub 2007 Jun 11.
4
Erlotinib alone or with bevacizumab as first-line therapy in patients with advanced non-squamous non-small-cell lung cancer harbouring EGFR mutations (JO25567): an open-label, randomised, multicentre, phase 2 study.厄洛替尼单药或联合贝伐珠单抗作为 EGFR 突变的晚期非鳞状非小细胞肺癌患者的一线治疗（JO25567）：一项开放标签、随机、多中心、Ⅱ期研究。
Lancet Oncol. 2014 Oct;15(11):1236-44. doi: 10.1016/S1470-2045(14)70381-X. Epub 2014 Aug 27.
5
Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study.厄洛替尼与贝伐单抗用于复发性或转移性头颈部鳞状细胞癌患者：一项I/II期研究
Lancet Oncol. 2009 Mar;10(3):247-57. doi: 10.1016/S1470-2045(09)70002-6. Epub 2009 Feb 7.
6
Sustained complete response after maintenance therapy with topotecan and erlotinib for recurrent cervical cancer with distant metastases.拓扑替康和厄洛替尼维持治疗对伴有远处转移的复发性宫颈癌的持续完全缓解。
Case Rep Oncol. 2014 Jan 31;7(1):97-101. doi: 10.1159/000358916. eCollection 2014 Jan.
7
Targeted Therapeutic Approaches in Vulvar Squamous Cell Cancer (VSCC): Case Series and Review of the Literature.外阴鳞状细胞癌（VSCC）的靶向治疗方法：病例系列和文献复习。
Oncol Res. 2021 Mar 16;28(6):645-659. doi: 10.3727/096504020X16076861118243. Epub 2020 Dec 11.
8
Atypical diffuse bilateral cystic lung changes secondary to erlotinib treatment in a patient with metastatic non-small cell lung carcinoma: A case report and literature review.厄洛替尼治疗转移性非小细胞肺癌患者继发的非典型双侧弥漫性囊性肺改变：一例报告及文献复习
Mol Clin Oncol. 2018 Jul;9(1):92-95. doi: 10.3892/mco.2018.1620. Epub 2018 May 4.
9
Fatal interstitial lung disease associated with high erlotinib and metabolite levels. A case report and a review of the literature.与高厄洛替尼和代谢物水平相关的致命性间质性肺病。病例报告及文献复习。
Lung Cancer. 2012 Mar;75(3):391-7. doi: 10.1016/j.lungcan.2011.10.008. Epub 2011 Nov 17.
10
Successful Use of Erlotinib in Treating Recurrent Thymic Carcinoma: A Case Report.厄洛替尼成功用于治疗复发性胸腺癌：一例报告
World J Oncol. 2013 Oct;4(4-5):214-216. doi: 10.4021/wjon707w. Epub 2013 Sep 27.
引用本文的文献
1
A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors SWOG S1609: Vulvar Cancers.一项针对罕见肿瘤的双抗CTLA-4和抗PD-1阻断的II期篮子试验SWOG S1609：外阴癌。
Clin Cancer Res. 2025 Jan 17;31(2):308-315. doi: 10.1158/1078-0432.CCR-24-1957.
2
Vulvar cancer management and wrangling recurrent disease: A report from the society of gynecologic oncology journal club.外阴癌的管理与复发性疾病的应对：来自妇科肿瘤学会期刊俱乐部的报告
Gynecol Oncol Rep. 2023 Nov 28;50:101310. doi: 10.1016/j.gore.2023.101310. eCollection 2023 Dec.
3
Targeted Therapeutic Approaches in Vulvar Squamous Cell Cancer (VSCC): Case Series and Review of the Literature.外阴鳞状细胞癌（VSCC）的靶向治疗方法：病例系列和文献复习。
Oncol Res. 2021 Mar 16;28(6):645-659. doi: 10.3727/096504020X16076861118243. Epub 2020 Dec 11.
4
Modern treatment of vulvar cancer.外阴癌的现代治疗方法。
Radiol Oncol. 2020 Sep 22;54(4):371-376. doi: 10.2478/raon-2020-0053.
5
Molecular pathways in vulvar squamous cell carcinoma: implications for target therapeutic strategies.外阴鳞状细胞癌中的分子通路：对靶向治疗策略的影响。
J Cancer Res Clin Oncol. 2020 Jul;146(7):1647-1658. doi: 10.1007/s00432-020-03226-6. Epub 2020 Apr 25.
本文引用的文献
1
Decreased survival in EGFR gene amplified vulvar carcinoma.表皮生长因子受体（EGFR）基因扩增的外阴癌患者生存率降低。
Gynecol Oncol. 2008 Nov;111(2):289-97. doi: 10.1016/j.ygyno.2008.07.038. Epub 2008 Sep 3.
2
Recurrent metastatic vulvar carcinoma treated with cisplatin plus cetuximab.采用顺铂联合西妥昔单抗治疗复发性转移性外阴癌。
Int J Gynecol Cancer. 2008 Sep-Oct;18(5):1132-5. doi: 10.1111/j.1525-1438.2007.01145.x. Epub 2007 Nov 16.
3
Treatment of squamous cell vulvar cancer with the anti-EGFR tyrosine kinase inhibitor Tarceva.使用抗表皮生长因子受体（EGFR）酪氨酸激酶抑制剂特罗凯治疗外阴鳞状细胞癌。
Gynecol Oncol. 2007 Sep;106(3):628-30. doi: 10.1016/j.ygyno.2007.05.006. Epub 2007 Jun 11.
4
Enhancement of radiosensitivity by dual inhibition of the HER family with ZD1839 ("Iressa") and trastuzumab ("Herceptin").使用ZD1839（“易瑞沙”）和曲妥珠单抗（“赫赛汀”）双重抑制HER家族增强放射敏感性。
Int J Radiat Oncol Biol Phys. 2006 Oct 1;66(2):528-36. doi: 10.1016/j.ijrobp.2006.05.036.
5
EGFR expression is associated with groin node metastases in vulvar cancer, but does not improve their prediction.表皮生长因子受体（EGFR）的表达与外阴癌腹股沟淋巴结转移相关，但并未改善对其的预测。
Gynecol Oncol. 2007 Jan;104(1):109-13. doi: 10.1016/j.ygyno.2006.07.035. Epub 2006 Sep 11.
6
Surviving cell death through epidermal growth factor (EGF) signal transduction pathways: implications for cancer therapy.通过表皮生长因子（EGF）信号转导通路在细胞死亡中存活：对癌症治疗的启示。
Cell Signal. 2006 Dec;18(12):2089-97. doi: 10.1016/j.cellsig.2006.05.015. Epub 2006 May 24.
7
Epidermal growth factor receptor in vulvar malignancies and its relationship to metastasis and patient survival.外阴恶性肿瘤中的表皮生长因子受体及其与转移和患者生存的关系。
Gynecol Oncol. 1997 Jun;65(3):425-9. doi: 10.1006/gyno.1997.4660.
8
Combined preoperative chemoradiotherapy followed by radical surgery in locally advanced vulvar carcinoma. A pilot study.局部晚期外阴癌术前同步放化疗后行根治性手术：一项前瞻性研究。
Cancer. 1996 Apr 15;77(8):1472-8. doi: 10.1002/(SICI)1097-0142(19960415)77:8<1472::AID-CNCR8>3.0.CO;2-E.
9
Chemotherapy of squamous cell carcinoma of the vulva: a review.
Gynecol Oncol. 1979 Jun;7(3):345-8. doi: 10.1016/0090-8258(79)90112-4.
Zotero 插件